Skip to Main Content

Paper Details

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2.
Pathogens
3
2022
Antibody sequence, GIGA, GIGA-2050, GIGA-2050 master cell bank, Recombinant Hyperimmune Globulin, SARS, SARS-CoV, SARS-CoV-2, cell line, human, hyperimmune globulin, immunoglobulins, mice, recombinant human IgG1 antibodies, recombinant hyperimmune globulin, recombinant hyperimmune globulins
Author NameAffiliation
Sheila M KeatingInc.
Chengjin YeTexas Biomedical Research Institute
Luis Martinez-SobridoTexas Biomedical Research Institute
Luis Martinez-SobridoTexas Biomedical Research Institute
David S JohnsonInc.
  • 1 - 5

Datasets

Release 1.2